Editorial
Published on 28 Sep 2023
Editorial: MOGAD, current knowledge and future trends
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1283217
- 1,697 views
Type at least 3 characters
1,117 articles
Editorial
Published on 26 Sep 2023
Editorial: Oxidative stress and neuroinflammatory responses associated with metal toxicity in brain disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1283653
- 1,298 views
Original Research
Published on 21 Sep 2023
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1265354
- 2,498 views
- 10 citations
Review
Published on 15 Sep 2023
Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1260358
- 11,694 views
- 33 citations
Original Research
Published on 13 Sep 2023
Health behaviors of people with multiple sclerosis and its associations with MS related outcomes: a German clinical cohort
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1172419
- 2,378 views
- 3 citations
Brief Research Report
Published on 08 Sep 2023
Inhibiting microglia exacerbates the early effects of cuprizone in males in a rat model of multiple sclerosis, with no effect in females
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.989132
- 2,402 views
- 2 citations
Systematic Review
Published on 07 Sep 2023
The use of intravenous immunoglobulin in the treatment of Hashimoto’s encephalopathy: case based review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1243787
- 5,662 views
- 4 citations
Original Research
Published on 06 Sep 2023
Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking software
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1243594
- 4,379 views
- 6 citations
Original Research
Published on 06 Sep 2023
Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1243589
- 2,353 views
- 1 citation
Case Report
Published on 01 Sep 2023
Case report: Acute necrotizing encephalopathy: a report of a favorable outcome and systematic meta-analysis of outcomes with different immunosuppressive therapies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1239746
- 5,929 views
- 6 citations
Original Research
Published on 25 Aug 2023
Olfactory dysfunction after autoimmune encephalitis depending on the antibody type and limbic MRI pathologies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1225975
- 1,894 views
- 2 citations
Case Report
Published on 17 Aug 2023
Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1208977
- 2,044 views
- 1 citation
Original Research
Published on 10 Aug 2023
Distinct characteristics and severity of brain magnetic resonance imaging lesions in women and men with multiple sclerosis assessed using verified texture analysis measures
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1213377
- 1,287 views
- 1 citation
Case Report
Published on 10 Aug 2023
The MOG antibody associated encephalitis preceded by COVID-19 infection; a case study and systematic review of the literature
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1239657
- 3,000 views
Original Research
Published on 09 Aug 2023
Objective assessment of dysarthric disorders in patients with multiple sclerosis depending on sex, age, and type of text read
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1225754
- 2,761 views
- 2 citations
Original Research
Published on 08 Aug 2023
Lacunes are associated with late-stage multiple sclerosis comorbidities
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2023.1224748
- 2,159 views
- 1 citation